Form 4 for IRMD IRADIMED CORP
Accepted 2022-12-16 00:00:00 ET · period of report 2022-12-15 · accession 0000898432-22-000666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-16 | 2022-12-15 | IRMD | GLENN JOHN | CFO | A - Grant | $28.67 | +2,500 | 2,500 | New | +$71.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | A | A | 2,500 | $28.67 | 2,500 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $28.61 to $28.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |